Michael Virata
MD, FIDSA, FACP
he/him/his
Associate Professor Term; Director, HIV Clinical Services, Internal Medicine; Associate Professor of Clinical Internal Medicine, Yale Medicine
Research & Publications
Biography
News
Locations
Research Summary
My research experience is focused mainly with the clinical aspects of HIV/AIDS. I am a principal investigator for a number of clinical trials at Yale particularly with novel antimicrobial agents in the realm of multidrug resistant organisms such MRSA and Pseudomonas.
I also have an interest in understanding the epidemiology of MRSA infections and virulence factors associated with bloodstream infectious.
Coauthors
Selected Publications
- Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and ReflectionsGleeson S, Zapata H, Bathgate M, Emu B, Frederick J, Friedland G, Golden M, Meyer J, Radin J, Sideleau R, Shaw A, Shenoi S, Trubin P, Virata M, Barakat L, Desruisseaux M. Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections. Clinical Infectious Diseases 2023, 77: 703-710. PMID: 37078888, DOI: 10.1093/cid/ciad236.
- 87. Infectious Disease Diversity, Equity, and Antiracism (ID2EA): A Dedicated Curriculum for Infectious Disease ProfessionalsGleeson S, Bathgate M, Frederick J, Desruisseaux M, Meyer J, Virata M, Zapata H, Shenoi S, Radin J, Golden M, Trubin P, Shaw A, Friedland G, Aoun-Barakat L. 87. Infectious Disease Diversity, Equity, and Antiracism (ID2EA): A Dedicated Curriculum for Infectious Disease Professionals. Open Forum Infectious Diseases 2021, 8: s55-s55. PMCID: PMC8644171, DOI: 10.1093/ofid/ofab466.087.
- 843. Targeted HIV Testing for Patients Hospitalized for COVID-19Virata M, Villanueva M, Miceli J. 843. Targeted HIV Testing for Patients Hospitalized for COVID-19. Open Forum Infectious Diseases 2021, 8: 512-512. PMCID: PMC8643876, DOI: 10.1093/ofid/ofab466.1038.
- 543. SARS-CoV-2 Viral Dynamics For Symptomatic People Living with HIV Requiring Hospitalization For COVID-19Virata M, Villanueva M, Shenoi S, Ladines-Lim J, Aoun-Barakat L. 543. SARS-CoV-2 Viral Dynamics For Symptomatic People Living with HIV Requiring Hospitalization For COVID-19. Open Forum Infectious Diseases 2020, 7: s338-s338. PMCID: PMC7777445, DOI: 10.1093/ofid/ofaa439.737.
- 111. Outcomes Related to COVID-19 Among People Living with HIV: Cohort from a Large Academic CenterVirata M, Shenoi S, Ladines-Lim J, Villanueva M, Aoun-Barakat L. 111. Outcomes Related to COVID-19 Among People Living with HIV: Cohort from a Large Academic Center. Open Forum Infectious Diseases 2020, 7: s184-s184. PMCID: PMC7777957, DOI: 10.1093/ofid/ofaa439.421.
- 566. Earlier Linkage and ART Initiation Via Fast Track Referral System for New HIV Patients Leads to Stronger Engagement and Better OutcomesVirata M, Comia C, Cudahy P. 566. Earlier Linkage and ART Initiation Via Fast Track Referral System for New HIV Patients Leads to Stronger Engagement and Better Outcomes. Open Forum Infectious Diseases 2018, 5: s210-s210. PMCID: PMC6255605, DOI: 10.1093/ofid/ofy210.574.
- Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patientsOgbuagu O, Hao R, Virata M, Villanueva M, Malinis M. Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients. F1000Research 2017, 6: 620. DOI: 10.12688/f1000research.11397.1.
- 673Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter EvaluationMoise P, Culshaw D, Wong-Beringer A, Bensman J, Lamp K, Smith W, Bauer K, Goff D, Adamson R, Leuthner K, Virata M, Mckinnell J, Chaudhry S, Eskandarian R, Lodise T, Reyes K, Zervos M. 673Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Open Forum Infectious Diseases 2014, 1: s190-s190. PMCID: PMC5781468, DOI: 10.1093/ofid/ofu052.381.
- PT271 Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral TherapyLombo B, Fotjadhi I, Ravi S, Golden M, Virata M, Lievano M, Diez J, Ghantous A, Donohue T. PT271 Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral Therapy. Global Heart 2014, 9: e219. DOI: 10.1016/j.gheart.2014.03.2016.
- Invasive Pneumococcal Disease: Clinical Features, Serotypes, and Antimicrobial Resistance Patterns in Cases Involving Patients with and Without Human Immunodeficiency Virus InfectionFrankel R, Virata M, Hardalo C, Altice F, Friedland G. Invasive Pneumococcal Disease: Clinical Features, Serotypes, and Antimicrobial Resistance Patterns in Cases Involving Patients with and Without Human Immunodeficiency Virus Infection. Clinical Infectious Diseases 1996, 23: 577-584. PMID: 8879783, DOI: 10.1093/clinids/23.3.577.